Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty

Clinical trial NCT06963320 · RECRUITING

Trial details

NCT number: NCT06963320
Sponsor: Livzon Pharmaceutical Group Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Circulatory Disease

Start date: 2025-01-20
Primary completion: 2025-06-30
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.